NASDAQ:MIST | Free Cash Flow | Milestone Pharmaceuticals Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$16.05M$45,000.00-$16.1M
2025-12-31-$12.78M$283,000.00-$13.06M
2025-03-31-$13.95M$6,000.00-$13.96M
2024-12-31-$6.84M$22,000.00-$6.87M
2024-03-31-$8.93M
2023-12-31-$9.8M$31,000.00-$9.83M
2023-03-31-$13.9M$32,000.00-$13.94M
2022-12-31-$12.86M$110,000.00-$12.97M
2022-03-31-$13.95M
2021-12-31-$12.38M
2021-03-31-$12.47M
2020-12-31-$8.76M
2020-03-31-$18.08M
2019-12-31-$16.6M$101,000.00-$16.7M
2019-03-31-$14.73M
2018-12-31-$7.31M$0.00-$7.31M
2018-03-31-$4.72M$5,000.00-$4.73M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$49.04M$302,000.00-$49.34M
2024-12-31-$28.85M$33,000.00-$28.88M
2023-12-31-$46.42M$112,000.00-$46.54M
2022-12-31-$52.47M$272,000.00-$52.74M
2021-12-31-$33.22M
2020-12-31-$50.73M
2019-12-31-$51.15M$413,000.00-$51.57M
2018-12-31-$21.05M$5,000.00-$21.05M